Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,812,377
-$2,711,123 QoQ
Shares Held
990,228
-40.0% QoQ
Ownership
0.679%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 226 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. MDXG ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in MDXG
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,812,377 | 990,228 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,523,500 | 1,651,519 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,344,394 | 1,380,265 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,632,134 | 1,093,429 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,244,914 | 1,185,747 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,195,892 | 946,828 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,054,432 | 733,309 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,287,606 | 894,688 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,001,129 | 865,964 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,658,984 | 734,933 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,835,910 | 437,390 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $693,344 | 95,109 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $675,687 | 102,222 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $229,796 | 67,389 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $113,132 | 32,603 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $272,748 | 45,157 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $1,134,689 | 110,164 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,472,020 | 272,249 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||